T1	Participants 248 399	19 ambulatory men with moderated essential hypertension (supine diastolic blood pressure [DPB], 100 to 120 mm Hg after receiving placebo for two weeks)
T2	Participants 438 510	The captopril group included 12 patients and the propranolol group seven
